Glimepiride CAS 93479-97-1 Insidiae 98.0%~ 102.0% API

Glimepiride CAS 93479-97-1 Intende 98.0%~ 102.0% API Factory

Description:

Nomen chemicum: Glimepiride

CAS: 93479-97-1

Aspectus: Alba vel fere Alba pulveris

Intenta: 98.0%~ 102.0%

Glimepiride in curatione Noninsulin-dependens Type 2 Diabete Mellitus

API High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Copia cum summa puritate et stabulo Quality
Nomen chemicum: Glimepiride
CAS: 93479-97-1
Glimepiride in curatione Noninsulin-dependens Type 2 Diabete Mellitus
API High Quality, Commercial Production

Chemical Properties:

Nomen chemicum	Glimepiride
Synonyma	Amaryl
CAS Number	93479-97-1
CATTUS Number	RF-API24
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C24H34N4O5S
M. Pondus	490.62
Liquescens punctum	212.2~ 214.5℃
Shipping Condition	Sub Ambient Temperature
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba aut fere Alba pulveris
Lepidium sativum	IR.
Substantiae cognatae
Cis-Isomer (A)	≤0.80%
Sulfonamide (B)	≤0.40%
Urethane (C)	≤0.10%
3-Isomer (D)	≤0.20%
Alia immunditia	≤0.10%
Totalis immunditias	≤0.50%
Damnum in Siccatio	≤0.50%
Residere in Ignition	≤0.10%
Metalla gravis	≤0.001%
Assay	98.0%~ 102.0%
Test Standard	Pharmacopeia Europaea (EP);Pharmacopoeia Civitatum Foederatarum (USP)
Consuetudinem	Active Pharmaceutical Ingredient (API)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

FAQ:

Applicatio:

Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica et supplementum Glimepiridis (CAS: 93479-97-1) cum qualitate alta, activum medicamentum pharmaceuticum (API).Glimepiride medicamentum antidiabeticum est quod sanguinem saccharo aequat moderari adiuvat.Glimepirida est actio longa, tertia generatio sulfonylurea cum actione hypoglycemica.

Glimepiride (nomen artis originis Amaryl) ore promptum est medium-ad-longum medicamentum sulfonylurea antidiabeticum.Sicut omnes sulfonylureas, glimepiride agit ut secretagoga insulina.Sanguinem saccharo demittit movendo emissionem insulinum ab operando cellas pancreaticae betae et sensitivum fibrarum peripheralium ad insulinum augendo.Glimepirida verisimile alligat receptatores canalis sensitivi ATP-sensitivo super superficiem cellae pancreaticae, conductionem potassium reducendo et membranae depolarizationem causantem.Membrana depolarizationis influxum calcium Ion excitat per canales calcii sensitivos.Hoc incrementum in concentratio calcii intracellularis secretionem insulinae inducit.Glimepiride imprimis aegros cum diabete speciebus 2 tractandis adhiberi potest et casus quoque minuere potest quos inpedimenta generis diabete 2 diabete explicabit.Medicamentum ab FDA anno 1995 probatum est et ab Sanofi-Aventis fabricatum est.Adhiberi potest una cum propria victu et ratione exercitationis et etiam sola vel cum aliis medicamentis antidiabeticis, si opus est, adhiberi.Glimepiride uti potest vel in monotherapia vel in compositione cum insulino.